Chen, X.; Xie, X.; Wang, X.; Wei, M.; Li, Z.; Li, L.
Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer. Curr. Oncol. 2023, 30, 9346-9356.
https://doi.org/10.3390/curroncol30100676
AMA Style
Chen X, Xie X, Wang X, Wei M, Li Z, Li L.
Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer. Current Oncology. 2023; 30(10):9346-9356.
https://doi.org/10.3390/curroncol30100676
Chicago/Turabian Style
Chen, Xi, Xinyu Xie, Xiaodong Wang, Mingtian Wei, Zhigui Li, and Li Li.
2023. "Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer" Current Oncology 30, no. 10: 9346-9356.
https://doi.org/10.3390/curroncol30100676
APA Style
Chen, X., Xie, X., Wang, X., Wei, M., Li, Z., & Li, L.
(2023). Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer. Current Oncology, 30(10), 9346-9356.
https://doi.org/10.3390/curroncol30100676